Form D · Biotechnology
AIM ImmunoTech Inc.
Ocala, FL · CIK 0000946644
Offering snapshot reported Feb 21, 2024 · SEC filing
- Reported sold
- $3.3M Offering amount: $3.3M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $2.5M Reported outside-investor minimum
- First sale
- Feb 16, 2024 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2024 | Amendment | $3,301,250 | $0vs Feb 20, 2024 | 1 | SEC filing |
| Feb 20, 2024 | Initial | $3,301,250 | No comparison | 1 | SEC filing |
| Apr 25, 2018 | Initial | $25,740 | No comparison | 3 | SEC filing |
| Feb 13, 2017 | Initial | $18,182 | No comparison | 4 | SEC filing |
| Sep 2, 2016 | Initial | $33,334 | No comparison | 3 | SEC filing |
| Jul 25, 2003 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $130K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-505650
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ascendiant Capital Markets, LLC | 152912 |
Source: Form D, filed Feb 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stewart Appelrouth | Director |
| Nancy Bryan | Director |
| Rob Dickey | Executive |
| Thomas Equals | Director, Executive |
| Thomas K Equels | Director, Executive |
| William Mitchell | Director |
| Adam Pascale | Executive |
| Peter Rodino | Executive |
| Wayne Springate | Executive |
| David Strayer | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Ocala, FL, 32801